Read

Members
Client Resources
Pharmacy + Provider Resources
Drug Recalls
Events

Who we are
Our solutions
Read, watch, listen
Pharmacy
Careers

Members
Client Resources
Pharmacy + Provider Resources
Drug Recalls
Events

Home
Read, watch, listen
Read

Explore what's trending at Prime

https://primetherapeutics.com/w/from-data-to-decisions-prime-s-glp-1-insights-inform-clinical-strategy Example Link

GLP-1, Products, Stories

From data to decisions: Prime’s GLP-1 insights inform clinical strategy

October 16, 2025

https://primetherapeutics.com/w/prime-presents-at-hlth-usa-conference-on-oct-20

Events

Prime presents at HLTH USA conference on Oct. 20

October 17, 2025

https://primetherapeutics.com/w/from-data-to-decisions-prime-s-glp-1-insights-inform-clinical-strategy

Stories

From data to decisions: Prime’s GLP-1 insights inform clinical strategy

October 16, 2025

https://primetherapeutics.com/w/prime-careers-spotlight-october-2025 /prime-careers-spotlight-october-2025

Stories

Prime Careers Spotlight: October 2025

October 15, 2025

The Latest

Categories

PA Sub-Categories

https://primetherapeutics.com/w/prime-therapeutics-engages-pwc-to-support-judi-platform-implementations

Prime Therapeutics Engages PwC to Support Judi® Platform Implementations

October 01, 2025

https://primetherapeutics.com/w/what-s-driving-medical-benefit-spend-prime-therapeutics-trend-report-shares-new-clues

What's driving medical benefit spend? Prime Therapeutics trend report shares new clues

September 04, 2025

https://primetherapeutics.com/w/prime-therapeutics-leading-research-shows-only-1-in-12-remain-on-a-glp-1-drug-for-obesity-at-three-years

Prime Therapeutics’ leading research shows only 1 in 12 remain on a GLP-1 drug for obesity at three years

June 25, 2025

https://primetherapeutics.com/w/prime-therapeutics-highlights-industry-leading-glp-1-research-at-amcp-2025

Prime Therapeutics highlights industry-leading GLP-1 research at AMCP 2025

March 31, 2025

https://primetherapeutics.com/w/prime-therapeutics-glp-1-research-year-2-cost-of-care-is-4-200-higher-for-patients-with-obesity

Prime Therapeutics GLP-1 research: Year-2 cost of care is $4,200 higher for patients with obesity

October 24, 2024

https://primetherapeutics.com/w/medical-benefit-drug-trend-prime-therapeutics-medical-pharmacy-trend-report-goes-behind-the-numbers-2024

Medical benefit drug trend: Prime Therapeutics Medical Pharmacy Trend Report™ goes behind the numbers

October 15, 2024

Showing 1 to 6 of 38

Categories

PA Sub-Categories

https://primetherapeutics.com/w/15-years-of-insight-prime-s-medical-pharmacy-trend-report-a-must-read-for-payers

15 years of insight: Prime’s Medical Pharmacy Trend Report — A must-read for payers

October 02, 2025

https://primetherapeutics.com/w/abby-kim-leads-the-charge-in-advancing-lung-cancer-care

Abby Kim leads the charge in advancing lung cancer care

October 01, 2025

https://primetherapeutics.com/w/making-sense-of-most-favored-nation-and-other-proposed-health-care-policies

Making sense of most favored nation and other proposed health care policies

September 30, 2025

https://primetherapeutics.com/w/prime-s-biosimilar-strategy-drives-optionality-for-health-plans

Prime’s biosimilar strategy drives optionality for health plans

August 07, 2025

https://primetherapeutics.com/w/prime-refines-the-way-it-serves-medicare-clients-and-members

Prime refines the way it serves Medicare clients and members

July 29, 2025

https://primetherapeutics.com/w/what-s-next-in-the-glp-1-pipeline-prime-s-clinical-team-shares-the-latest

What’s next in the GLP-1 pipeline? Prime’s clinical team shares the latest

June 18, 2025

Showing 1 to 6 of 64

Categories

PA Sub-Categories

https://primetherapeutics.com/w/from-data-to-decisions-prime-s-glp-1-insights-inform-clinical-strategy

From data to decisions: Prime’s GLP-1 insights inform clinical strategy

October 16, 2025

https://primetherapeutics.com/w/prime-careers-spotlight-october-2025 /prime-careers-spotlight-october-2025

Prime Careers Spotlight: October 2025

October 15, 2025

https://primetherapeutics.com/w/prime-s-strategic-vision-for-smarter-member-centered-breast-cancer-care

Prime’s strategic vision for smarter, member-centered breast cancer care

October 15, 2025

https://primetherapeutics.com/w/how-prime-supports-families-experiencing-pediatric-cancer

How Prime supports families experiencing pediatric cancer

October 14, 2025

https://primetherapeutics.com/w/cancer-care-reimagined-how-prime-is-making-innovation-personal

Cancer care, reimagined: How Prime is making innovation personal

October 07, 2025

https://primetherapeutics.com/w/hear-the-latest-health-care-trends-from-prime-s-2025-specialty-summit

Hear the latest health care trends from Prime’s 2025 Specialty Summit

October 02, 2025

Showing 1 to 6 of 148

Categories

PA Sub-Categories

https://primetherapeutics.com/w/prime-presents-at-hlth-usa-conference-on-oct-20

Prime presents at HLTH USA conference on Oct. 20

October 17, 2025

https://primetherapeutics.com/w/prime-presents-2025-medical-pharmacy-trend-report-webcast-on-oct-13

Prime presents 2025 Medical Pharmacy Trend Report webcast on Oct. 13

September 23, 2025

https://primetherapeutics.com/w/prime-expert-presents-at-the-most-favored-nation-mandate-webinar

Prime expert presents at “The Most Favored Nation Mandate” webinar on Sept. 10

September 02, 2025

https://primetherapeutics.com/w/prime-presents-at-national-association-of-specialty-pharmacy-nasp-annual-meeting-from-sept-14-17

Prime presents at National Association of Specialty Pharmacy (NASP) annual meeting from Sept. 14–17

August 25, 2025

https://primetherapeutics.com/w/prime-presents-at-isg-digital-business-summit-on-nov-14

Prime presents at ISG Digital Business Summit on Nov. 14

November 05, 2024

https://primetherapeutics.com/w/prime-presents-at-amcp-nexus-2024

Prime presents at AMCP Nexus 2024 on Oct. 14–17

September 30, 2024

Showing 1 to 6 of 36

Categories

PA Sub-Categories

https://primetherapeutics.com/w/specialty-pharmacy-continuum-addressing-inequities-in-food-allergy-prevention-and-treatment https://www.specialtypharmacycontinuum.com/Clinical/Article/10-25/Addressing-Inequities-in-Food-Allergy-Prevention-and-Treatment/78403

Specialty Pharmacy Continuum: Addressing Inequities in Food Allergy Prevention and Treatment

October 06, 2025

https://primetherapeutics.com/w/payer-perspectives-prime-provides-integrated-medical-pharmacy-claims-data-for-certain-classes https://payerperspectives.substack.com/p/prime-provides-integrated-medical

Payer Perspectives: Prime Provides Integrated Medical, Pharmacy Claims Data for Certain Classes

October 02, 2025

https://primetherapeutics.com/w/fda-drops-rems-for-car-t-rx-will-access-expand- https://www.pharmacypracticenews.com/Clinical/Oncology/Article/09-25/FDA-Removes-CAR-T-REMS/78266

Pharmacy Practice News: FDA Drops REMS for CAR-T Rx; Will Access Expand?

September 25, 2025

https://primetherapeutics.com/w/what-the-president-s-drug-pricing-push-means-for-pharma-payers-and-patients https://www.pharmexec.com/view/president-drug-pricing-push-payers-patients

PharmExec.com: What the President’s Drug Pricing Push Means for Pharma, Payers, and Patients

September 11, 2025

https://primetherapeutics.com/w/experts-throw-cold-water-on-the-idea-that-dtc-platforms-will-meaningfully-lower-drug-prices https://www.mmm-online.com/news/trump-lower-drug-prices-dtc-platforms/

Medical Marketing and Media: Experts throw cold water on the idea that DTC platforms will meaningfully lower drug prices

September 08, 2025

https://primetherapeutics.com/w/rising-cancer-drug-costs-calls-for-collaboration-and-value-based-care-pbmi-2025 https://www.managedhealthcareexecutive.com/view/rising-cancer-drug-costs-calls-for-collaboration-and-value-based-care-pbmi-2025

Managed Healthcare Executive: Rising Cancer Drug Costs Calls for Collaboration and Value-Based Care | PBMI 2025

September 05, 2025

Showing 1 to 6 of 119

Categories

PA Research & Publications

https://primetherapeutics.com/w/high-cost-therapy-profile-october-2025 /high-cost-therapy-profile-october-2025

High-Cost Therapy Profile: October 2025

October 15, 2025

https://primetherapeutics.com/w/fda-decisions-expected-november-2025 /fda-decisions-expected-november-2025

FDA Decisions Expected: November 2025

October 13, 2025

https://primetherapeutics.com/w/reimagine-cancer-care-insights-that-drive-smarter-decisions /fall-2025-prime-therapeutics-report

Fall 2025 Prime Therapeutics Report: Reimagining Cancer Care

October 07, 2025

https://primetherapeutics.com/w/2025-medicaid-pharmacy-trend-report /2025-medicaid-pharmacy-trend-report

2025 Medicaid Pharmacy Trend Report

October 01, 2025

https://primetherapeutics.com/w/trending-topics-drug-approvals-september-2025 /trending-topics-drug-approvals-september-2025

High-Cost Therapy Profile: September 2025

September 22, 2025

Showing 1 to 6 of 176

Login Portals

Members and Consumers
Clients and Health Plans
Pharmacy + Provider Resources

Compliance / Legal

Privacy Policy
Notice of Privacy Practices
Terms of Use
Nondiscrimination + Languages
Subrogation

Company

About us
Careers
News
Media

Read &#8211; News, Research &amp; Insights from Prime Therapeutics - Prime Therapeutics

About us

Corporate social responsibility

Solutions overview

Modern technology

Drug access

Clinical solutions

Condition management

Specialty drug management

Government solutions

Single-state programs

Watch

Listen

Home Delivery

Specialty Pharmacy

Navigate to

Back

Back

Back

Back

Explore what's trending at Prime

From data to decisions: Prime’s GLP-1 insights inform clinical strategy

Prime presents at HLTH USA conference on Oct. 20

From data to decisions: Prime’s GLP-1 insights inform clinical strategy

Prime Careers Spotlight: October 2025

The Latest

Prime Therapeutics Engages PwC to Support Judi® Platform Implementations

What's driving medical benefit spend? Prime Therapeutics trend report shares new clues

Prime Therapeutics’ leading research shows only 1 in 12 remain on a GLP-1 drug for obesity at three years

Prime Therapeutics highlights industry-leading GLP-1 research at AMCP 2025

Prime Therapeutics GLP-1 research: Year-2 cost of care is $4,200 higher for patients with obesity

Medical benefit drug trend: Prime Therapeutics Medical Pharmacy Trend Report™ goes behind the numbers

15 years of insight: Prime’s Medical Pharmacy Trend Report — A must-read for payers

Abby Kim leads the charge in advancing lung cancer care

Making sense of most favored nation and other proposed health care policies

Prime’s biosimilar strategy drives optionality for health plans

Prime refines the way it serves Medicare clients and members

What’s next in the GLP-1 pipeline? Prime’s clinical team shares the latest

From data to decisions: Prime’s GLP-1 insights inform clinical strategy

Prime Careers Spotlight: October 2025

Prime’s strategic vision for smarter, member-centered breast cancer care

How Prime supports families experiencing pediatric cancer

Cancer care, reimagined: How Prime is making innovation personal

Hear the latest health care trends from Prime’s 2025 Specialty Summit

Prime presents at HLTH USA conference on Oct. 20

Prime presents 2025 Medical Pharmacy Trend Report webcast on Oct. 13

Prime expert presents at “The Most Favored Nation Mandate” webinar on Sept. 10

Prime presents at National Association of Specialty Pharmacy (NASP) annual meeting from Sept. 14–17

Prime presents at ISG Digital Business Summit on Nov. 14

Prime presents at AMCP Nexus 2024 on Oct. 14–17

Specialty Pharmacy Continuum: Addressing Inequities in Food Allergy Prevention and Treatment

Payer Perspectives: Prime Provides Integrated Medical, Pharmacy Claims Data for Certain Classes

Pharmacy Practice News: FDA Drops REMS for CAR-T Rx; Will Access Expand?

PharmExec.com: What the President’s Drug Pricing Push Means for Pharma, Payers, and Patients

Medical Marketing and Media: Experts throw cold water on the idea that DTC platforms will meaningfully lower drug prices

Managed Healthcare Executive: Rising Cancer Drug Costs Calls for Collaboration and Value-Based Care | PBMI 2025

High-Cost Therapy Profile: October 2025

FDA Decisions Expected: November 2025

Fall 2025 Prime Therapeutics Report: Reimagining Cancer Care

2025 Medicaid Pharmacy Trend Report

Trending Topics & Drug Approvals: September 2025

High-Cost Therapy Profile: September 2025

Login Portals

Compliance / Legal

Company

Read – News, Research & Insights from Prime Therapeutics - Prime Therapeutics